Last reviewed · How we verify

adapalene gel, 0.3%

Galderma R&D · FDA-approved active Small molecule

Adapalene is a third-generation retinoid that binds to retinoic acid receptors (RARs) to normalize skin cell differentiation and reduce inflammation.

Adapalene is a third-generation retinoid that binds to retinoic acid receptors (RARs) to normalize skin cell differentiation and reduce inflammation. Used for Acne vulgaris, Photoaging and fine wrinkles (off-label use in some regions).

At a glance

Generic nameadapalene gel, 0.3%
Also known asDifferin® 0.3% Gel, Differin® Gel, 0.3%
SponsorGalderma R&D
Drug classRetinoid (third-generation)
TargetRetinoic acid receptors (RARγ, RARα, RARβ)
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved

Mechanism of action

Adapalene selectively activates retinoic acid receptor gamma (RARγ) and other RAR subtypes, promoting keratinocyte differentiation and reducing sebum production. It decreases comedone formation and has anti-inflammatory properties, making it effective for treating acne by normalizing follicular epithelial desquamation and reducing bacterial colonization.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results